These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6407766)

  • 1. [Pharmacokinetic properties of the delayed-action form of lithium carbonate].
    Kabes J; Kabesová L
    Cesk Psychiatr; 1983 Apr; 79(2):102-6. PubMed ID: 6407766
    [No Abstract]   [Full Text] [Related]  

  • 2. Single-dose bioavailability of two extended-release lithium carbonate products.
    Kirkwood CK; Wilson SK; Hayes PE; Barr WH; Sarkar MA; Ettigi PG
    Am J Hosp Pharm; 1994 Feb; 51(4):486-9. PubMed ID: 8017413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serum lithium levels after slow-release and regular tablets of lithium carbonate].
    Kauko K; Viukari M
    Duodecim; 1973; 89(19):1324-8. PubMed ID: 4757404
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical trial of contemnol tablets (lithium retard Spofa)].
    König L; Lange E
    Psychiatr Neurol Med Psychol (Leipz); 1987 Apr; 39(4):230-3. PubMed ID: 3110815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability of lithium carbonate and lithium citrate: a comparison of two controlled-release preparations.
    Tyrer SP; Peat MA; Minty PS; Luchini A; Glud V; Amdisen A
    Pharmatherapeutica; 1982; 3(4):243-6. PubMed ID: 6815664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative characteristics of the preventive properties of short-acting and delayed-action lithium carbonate in endogenous affective psychoses].
    Panteleeva GP; Mikhaĭlova NM; Beliaev BS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(3):406-12. PubMed ID: 6789585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of dosage schedules for delayed-action lithium carbonate].
    Balon R; Kabesh Ia
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(2):264-6. PubMed ID: 6803477
    [No Abstract]   [Full Text] [Related]  

  • 8. A pharmacokinetic analysis of lithium carbonate absorption from several formulations in man.
    Caldwell HC; Westlake WJ; Connor SM; Flanagan T
    J Clin Pharmacol New Drugs; 1971; 11(5):349-56. PubMed ID: 5208514
    [No Abstract]   [Full Text] [Related]  

  • 9. Lithium carbonate 24-hour extended-release capsule filled with 6 mm tablets.
    Pietkiewicz P; Sznitowska M; Dorosz A; Lukasiak J
    Boll Chim Farm; 2003; 142(2):69-71. PubMed ID: 12705093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Voluntary lithium salt poisoning; risks of slow release forms].
    Branger B; Peyrière H; Zabadani B; Vécina F; Abbar M
    Nephrologie; 2000; 21(6):291-3. PubMed ID: 11117108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation of sustained - release lithium carbonate matrix tablets: influence of hydrophilic materials on the release rate and in vitro-in vivo evaluation.
    Emami J; Tavakoli N; Movahedian A
    J Pharm Pharm Sci; 2004 Nov; 7(3):338-44. PubMed ID: 15576014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lithium absorption from ordinary and from sustained-release tablets.
    Otto U; Paalzow L; Surén G
    Acta Pharm Suec; 1972 Dec; 9(6):595-601. PubMed ID: 4656566
    [No Abstract]   [Full Text] [Related]  

  • 13. Aspect of the pharmacokinetics of slow-release lithium carbonate.
    Hart GA
    S Afr Med J; 1984 Aug; 66(5):178-9. PubMed ID: 6431618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Slow-release lithium carbonate.
    Coppen A; Bailey JE; White SG
    J Clin Pharmacol J New Drugs; 1969; 9(3):160-2. PubMed ID: 5255180
    [No Abstract]   [Full Text] [Related]  

  • 15. How does the patient prefer his lithium treatment?
    Vestergaard P
    Pharmacopsychiatry; 1985 May; 18(3):223-4. PubMed ID: 4011670
    [No Abstract]   [Full Text] [Related]  

  • 16. Prediction of lithium carbonate dosage in psychiatric inpatients using the repeated one-point method.
    Marr MA; Djuric PE; Ritschel WA; Garver DL
    Clin Pharm; 1983; 2(3):243-8. PubMed ID: 6411413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of the excretion curves of 2 lithium salt preparations: carbonate slow-release sulfate (pharmacological and statistical study)].
    Rutigliano G; Chieppa M; Leonetti S
    Acta Neurol (Napoli); 1974; 29(1):77-92. PubMed ID: 4828165
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the pharmacokinetics of a new application form of lithium with protracted effect (author's transl)].
    Motýlová A; Molcan J; Chalabala M
    Cesk Psychiatr; 1978 Jun; 74(3):133-8. PubMed ID: 699123
    [No Abstract]   [Full Text] [Related]  

  • 19. [Slow-release lithium carbonate versus standard preparation in bipolar affective disorders (author's transl)].
    Bohacek N; Mihovilović M
    Lijec Vjesn; 1980 Oct; 102(10):575-9. PubMed ID: 6790888
    [No Abstract]   [Full Text] [Related]  

  • 20. Lithium absorption from sustained-release tablets (Duretter).
    Amdisen A; Sjögren J
    Acta Pharm Suec; 1968 Nov; 5(5):465-72. PubMed ID: 5732567
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.